Australian medical device innovator Epiminder raises $16m and expands clinical trial for epilepsy monitoring device

The bridge financing round was oversubscribed with strong support from private investors, as well as existing shareholders including medical device leader CochlearThe UMPIRE clinical trial will expand to multiple clinical…

Continue ReadingAustralian medical device innovator Epiminder raises $16m and expands clinical trial for epilepsy monitoring device

Australian medical technology innovators Epiminder and Seer Medical collaborate on epilepsy seizure detection and forecasting

Epiminder is developing Minder®, an ultra-long term EEG implant to monitor brain activity to improve the standard of care for epilepsy sufferers.Seer Medical is developing revolutionary cloud and app-based platforms…

Continue ReadingAustralian medical technology innovators Epiminder and Seer Medical collaborate on epilepsy seizure detection and forecasting

Epi-Minder appoints COO to lead execution of Minder™ — breakthrough device for epilepsy and seizure-related conditions

Epi-Minder Pty Ltd, a company developing the Minder™ ambulatory electroencephalography (EEG) monitoring device to transform clinical management of epilepsy and seizure-related conditions, is pleased to announce the appointment of Dr…

Continue ReadingEpi-Minder appoints COO to lead execution of Minder™ — breakthrough device for epilepsy and seizure-related conditions

Australian medical device innovator Epi-Minder raises $18m to develop its breakthrough epilepsy monitoring device

The Series A fund raising was strongly supported by private investors, as well as existing shareholders including medical device leader CochlearThe company is developing Minder™, a cloud-based, around-the-clock monitor that…

Continue ReadingAustralian medical device innovator Epi-Minder raises $18m to develop its breakthrough epilepsy monitoring device